Immunology and allergy

Prof Sinthia Bosnic-Anticevich
Podcasts iconPodcasts

It is essential to exclude patient barriers such as technique and adherence before concluding that the medication regime needs to be intensified. GPs are best placed to work through the complex issues with our patients

Prof Richard Harvey
Podcasts iconPodcasts

Tips and practical aids for more effective investigation, diagnosis and management

Dr Celia Zubrinich
Videos iconVideos

In this Product Explainer, Allergy Specialist Dr Celia Zubrinich gives a short introduction to Anapen®, used for the emergency treatment of anaphylaxis and explains how to use the Anapen® device. (6 mins).

Maria Said
Clinical Articles iconClinical Articles

Two adrenalin injectors are now available and this allows the patients a choice, but GPs need to be familiar with both devices.

Expert/s: Maria Said
Maria Said
Clinical Articles iconClinical Articles

Two adrenalin injectors are now available and this allows the patients a choice, but GPs need to be familiar with both devices.

Expert/s: Maria Said
Maria Said
Clinical Articles iconClinical Articles

Two adrenalin injectors are now available and this allows the patients a choice, but GPs need to be familiar with both devices.

Expert/s: Maria Said
Dr Rupert Hinds
Podcasts iconPodcasts

The symptoms and signs of CMPA in an infant and how to make the diagnosis through exclusion and rechallenge

Dr William Smith
Podcasts iconPodcasts

There are some groups of patients at higher risk of needing a second dose.

Prof Peter Richmond
Videos iconVideos

In this Product Explainer, Paediatrician and Paediatric Immunologist A/Prof Peter Richmond explains which patients are most at risk for meningococcal B, the risk reduction benefits of meningococcal B vaccination and why it is important to have conversations with parents in which the risk/benefits of vaccination are clearly explained (5 mins).

Prof Tony Cunningham AO
Videos iconVideos

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Dr Jessica Tattersall
Clinical Articles iconClinical Articles

Allergic and non-allergic rhinitis are extremely common and distressing conditions...

Dr Jessica Tattersall
Clinical Articles iconClinical Articles

Dr Jessica Tattersall discusses the importance of history in order to differentiate between the two and to maximise improvement.